RECRUITING

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the difference in patient-reported postoperative outcomes between two standard-of-care surgical techniques for radical orchiectomy (inguinal orchiectomy versus external oblique fascia sparing orchiectomy) for treatment of patients with suspected testicular malignancy. The main questions it aims to answer are: 1. Does sparing the external oblique fascia during orchiectomy reduce pain after surgery? 2. Is there a difference in narcotic consumption after surgery? 3. Is there a difference in neuropathic pain after surgery? 4. Is there a difference in complications after surgery?

Official Title

Patient Reported Experiences With Sparing ExteRnal Oblique Fascia Vs Standard Inguinal OrchiEctomy

Quick Facts

Study Start:2025-05
Study Completion:2029-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06828185

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants undergoing radical orchiectomy for suspected testicular malignancy
  2. * Testicular malignancy can be germ cell tumor or non germ cell tumors, including paratesticular tumors as long as a radical orchiectomy is planned
  3. * Participants over 18 years of age who can provide informed consent
  4. * Participants not currently using opiates for another reason
  5. * Regional and metastatic patients are allowed, as long as participant does not require opiates for pain related to metastatic disease
  6. * No contraindication for participant to receive standardized medication pathway in the peri-operative period.
  1. * Clinical T4 disease
  2. * History of illicit substance abuse (including prior opioid abuse) except for marijuana
  3. * Participants who underwent chemotherapy or radiotherapy prior to orchiectomy
  4. * Opioid use within 1 month of study enrollment
  5. * Participants with large testis masses requiring skin incision larger than 8 cm in size.
  6. * Participants with large testis masses requiring orchiectomy through an incision other than the standard transverse inguinal incision (i.e. hockey stick incision, vertical incision)

Contacts and Locations

Study Contact

Muhannad Alsyouf, MD
CONTACT
9095584000
Malsyouf@llu.edu
Brian Hu, MD
CONTACT
9095584000
Bhu@llu.edu

Study Locations (Sites)

Loma Linda University
Loma Linda, California, 92354
United States

Collaborators and Investigators

Sponsor: Loma Linda University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05
Study Completion Date2029-09

Study Record Updates

Study Start Date2025-05
Study Completion Date2029-09

Terms related to this study

Keywords Provided by Researchers

  • orchiectomy
  • postoperative pain
  • testis cancer
  • germ cell tumors

Additional Relevant MeSH Terms

  • Testicular Cancer